Thursday, December 1, 2011

Affymetrix Buys eBioscience

Santa Clara-based Affymetrix said Wednesday that it is acquiring eBioScience, a privately held developer of flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. The deal was worth $330M in cash. Privately held eBioscience was based in San Diego, California. Affymetrix said it is financing the deal with a $190M senior secured financing, including $20M in a revolving credit facility, from GE Capital, Healthcare Financial Services, Silicon Valley Bank, CIT Healthcare LLC and CIT Bank.